Assessment of pharmacokinetic (PK) and pharmacodynamic (PD) interaction between warfarin and repaglinide

被引：0
|
作者：
Rosenberg, M
Strange, P
Cohen, A
机构：
来源：
DIABETES | 1999年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1559
引用
收藏
页码：A356 / A356
页数：1
相关论文
共 50 条
  • [1] Assessment of the pharmacokinetic (PK), pharmacodynamic (PD) interaction potential between posaconazole and glipizide in healthy volunteers.
    Courtney, R
    Sansone, A
    Statkevich, P
    Martinho, M
    Laughlin, M
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) : P45 - P45
  • [2] NO PHARMACOKINETIC OR PHARMACODYNAMIC INTERACTION BETWEEN RIVASTATIN AND WARFARIN
    SCHALL, R
    MULLER, FO
    HUNDT, HKL
    RITTER, W
    DUURSEMA, L
    GROENEWOUD, G
    MIDDLE, MV
    JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 35 (03): : 306 - 313
  • [3] Lack of pharmacokinetic (PK) and pharmacodynamic (PD) interaction between the first synthetic factor Xa inhibitor and warfarin in human volunteers.
    Faaij, RA
    Burggraaf, J
    Cohen, AF
    BLOOD, 2000, 96 (11) : 56A - 56A
  • [4] Increased sensitivity to warfarin (W) with aging - A pharmacokinetic (PK) or pharmacodynamic (PD) phenomenon?
    Loebstein, R
    Peleg, D
    Almog, S
    Halkin, H
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P46 - P46
  • [5] Lack of pharmacokinetic and pharmacodynamic interaction between valsartan and warfarin
    Knight, H
    Flesch, G
    Prasad, P
    Lloyd, P
    Douglas, J
    JOURNAL OF HYPERTENSION, 2000, 18 : S89 - S89
  • [6] A PHARMACOKINETIC/PHARMACODYNAMIC INTERACTION STUDY BETWEEN CARISBAMATE AND WARFARIN
    Gonzalez, Martha D.
    Zannikos, Peter
    Ariyawansa, Jay
    Brashcar, H. Robert
    Romano, Gary
    Janssen, Tom
    JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (09): : 1116 - 1116
  • [7] Pharmacokinetic and pharmacodynamic drug-drug interaction assessment between pradigastat and digoxin or warfarin
    Yan, Jing-He
    Meyers, Dan
    Lee, Zachary
    Danis, Kate
    Neelakantham, Srikanth
    Majumdar, Tapan
    Rebello, Sam
    Sunkara, Gangadhar
    Chen, Jin
    JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (07): : 800 - 808
  • [8] Pharmacokinetic and Pharmacodynamic Interaction Between Tolvaptan and Warfarin in Healthy Subjects
    Shoaf, Susan E.
    Mallikaarjun, Suresh
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2012, 1 (02): : 67 - 75
  • [9] COMBINED PHARMACOKINETIC PHARMACODYNAMIC (PK/PD) MODELING
    COLBURN, WA
    JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 28 (09): : 769 - 771
  • [10] Pharmacokinetic (PK) and pharmacodynamic (PD) interactions between fluvoxamine and olanzapine.
    Maenpaa, J
    Wrighton, S
    Bergstrom, R
    Cerimele, B
    Tatum, D
    Hatcher, B
    Callaghan, JT
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (02) : PIV8 - PIV8
12345